tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see NMRA full AI Analyst Report?

Neumora Therapeutics, Inc. (NMRA) Stock News & Sentiment

419 Followers
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
Premium
Ratings
Ami Fadia Reiterates Buy on Neumora, Sees Compelling Risk-Reward Ahead of Phase 3 Readouts with Unchanged $8 Price Target
6h ago
NMRA
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
Premium
Ratings
Analyst Initiates Buy on Neumora, Citing Compelling Risk/Reward Ahead of Key Navacaprant Readouts and Broader Pipeline Upside
7d ago
NMRA
Neumora: Deep Pipeline and Near‑Term Clinical Catalysts Support Attractive Risk‑Reward and Buy Rating
Premium
Ratings
Neumora: Deep Pipeline and Near‑Term Clinical Catalysts Support Attractive Risk‑Reward and Buy Rating
1M ago
NMRA
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
Premium
Company Announcements
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
1M ago
NMRA
Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access
Premium
Company Announcements
Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access
1M ago
NMRA
Options Volatility and Implied Earnings Moves Today, March 30, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 30, 2026
2M ago
CBAT
DFDV
NMRA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NMRA Earnings this Week: How Will it Perform?
2M ago
NMRA
More NMRA News >

NMRA News on the Web

Neumora: Deep Pipeline and Near‑Term Clinical Catalysts Support Attractive Risk‑Reward and Buy Rating
TipRanks News
Bullish
H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)
TipRanks News
Neutral
Neumora Therapeutics management to meet with Piper Sandler
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA) and Sandoz Group Ltd (OtherSDZXF)
TipRanks News
Neutral
Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Neumora Therapeutics, Inc. (NMRA) and Aurinia Pharmaceuticals (AUPH)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
NMRA
Sector Average
Media Buzz
This Week1 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NMRA’s Media Buzz Sentiment?
1 articles about NMRA were published this week. In an average week, 4 articles are published.
    What is NMRA’s weekly average amount of articles?
    In an average week, 4 articles about NMRA are published.
      What is NMRA’s News Sentiment?
      100% of articles about NMRA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week